This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Farnebo, F. Articles by Farnebo, L.-O. Search for Related Content PubMed PubMed Citation Articles by Farnebo, F. Articles by Farnebo, L.-O.

Tumor-Specific Decreased Expression of Calcium Sensing Receptor Messenger Ribonucleic Acid in Sporadic Primary Hyperparathyroidism¹

Department of Molecular Medicine (F.F., M.S., C.L.), Department of Clinical Pathology (L.G.), and Department of Surgery (U.E., M.B., L.-O.F.), Karolinska Hospital, Stockholm, Sweden

Address all correspondence and requests for reprints to: Filip Farnebo, Department of Molecular Medicine, Endocrine Tumor Unit L8:01, Karolinska Hospital, S-171 76 Stockholm, Sweden.

Secretion of PTH is regulated by extracellular calcium via calcium receptors (CaR) on the parathyroid cell surface. Recent studies have shown a decreased expression of CaR messenger RNA (mRNA) and CaR protein in pathological parathyroids. We studied the expression of CaR mRNA in pairs of adenoma and adenoma-associated normal gland from the same patients (n = 17) and in biopsies of normal parathyroid glands of normocalcemic subjects (n = 4) using in situ hybridization with oligonucleotide probes on frozen sections. No down-regulation of CaR mRNA caused by hypercalcemia could be demonstrated in the normal adenoma-associated parathyroids when compared with the normal parathyroids of normocalcemic subjects. In contrast, CaR mRNA in the adenomas was significantly reduced to 64% (median; range 41–98) of the corresponding normal adenoma-associated glands. No correlation was seen between CaR mRNA in the adenoma and preoperative serum calcium, PTH, or weight of the adenoma. Loss of heterozygosity studies were performed on adenomas using markers for the locus of the CaR gene on chromosome 3q. No allelic loss was demonstrated, excluding allelic loss as the cause for decreased CaR mRNA expression in the adenomas. It is concluded that the lowered levels of CaR mRNA in parathyroid adenomas may contribute to the increased set point of PTH secretion. In large adenomas the increased cell mass seems to be more important for the increased secretion of PTH.

This article has been cited by other articles:

				W.-O. Lui, L. Zeng, V. Rehrmann, S. Deshpande, M. Tretiakova, E. L. Kaplan, I. Leibiger, B. Leibiger, U. Enberg, A. Hoog, et al. CREB3L2-PPAR{gamma} Fusion Mutation Identifies a Thyroid Signaling Pathway Regulated by Intramembrane Proteolysis Cancer Res., September 1, 2008; 68(17): 7156 - 7164. [Abstract] [Full Text] [PDF]

				I. Titon, A. Cailleux-Bounacer, J. P. Basuyau, H. Lefebvre, A. Savoure, and J. M. Kuhn Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism Eur. J. Endocrinol., September 1, 2007; 157(3): 351 - 357. [Abstract] [Full Text] [PDF]

				N. Chattopadhyay Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E761 - E770. [Abstract] [Full Text] [PDF]

				D. R. Martin, C. S. Ritter, E. Slatopolsky, and A. J. Brown Acute regulation of parathyroid hormone by dietary phosphate Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E729 - E734. [Abstract] [Full Text] [PDF]

				L. Forsberg, E. Bjorck, J. Hashemi, J. Zedenius, A. Hoog, L.-O. Farnebo, M. Reimers, and C. Larsson Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology Eur. J. Endocrinol., March 1, 2005; 152(3): 459 - 470. [Abstract] [Full Text] [PDF]

				O. Kifor, I. Kifor, F. D. Moore Jr., R. R. Butters Jr., T. Cantor, P. Gao, and E. M. Brown Decreased Expression of Caveolin-1 and Altered Regulation of Mitogen-Activated Protein Kinase in Cultured Bovine Parathyroid Cells and Human Parathyroid Adenomas J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4455 - 4464. [Abstract] [Full Text] [PDF]

				O. Kifor, F. D. Moore Jr., M. Delaney, J. Garber, G. N. Hendy, R. Butters, P. Gao, T. L. Cantor, I. Kifor, E. M. Brown, et al. A Syndrome of Hypocalciuric Hypercalcemia Caused by Autoantibodies Directed at the Calcium-Sensing Receptor J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 60 - 72. [Abstract] [Full Text] [PDF]

				T. Dwight, A. E. Nelson, G. Theodosopoulos, A. L. Richardson, D. L. Learoyd, J. Philips, L. Delbridge, J. Zedenius, B. T. Teh, C. Larsson, et al. Independent Genetic Events Associated with the Development of Multiple Parathyroid Tumors in Patients with Primary Hyperparathyroidism Am. J. Pathol., October 1, 2002; 161(4): 1299 - 1306. [Abstract] [Full Text] [PDF]

				L. Canaff and G. N. Hendy Human Calcium-sensing Receptor Gene. VITAMIN D RESPONSE ELEMENTS IN PROMOTERS P1 AND P2 CONFER TRANSCRIPTIONAL RESPONSIVENESS TO 1,25-DIHYDROXYVITAMIN D J. Biol. Chem., August 9, 2002; 277(33): 30337 - 30350. [Abstract] [Full Text] [PDF]

				E. M. Brown and R. J. MacLeod Extracellular Calcium Sensing and Extracellular Calcium Signaling Physiol Rev, January 1, 2001; 81(1): 239 - 297. [Abstract] [Full Text] [PDF]

				F. Cetani, A. Picone, P. Cerrai, E. Vignali, S. Borsari, E. Pardi, P. Viacava, A. G. Naccarato, P. Miccoli, O. Kifor, et al. Parathyroid Expression of Calcium-Sensing Receptor Protein and in Vivo Parathyroid Hormone-Ca2+ Set-Point in Patients with Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4789 - 4794. [Abstract] [Full Text]

				T. Carling, J. Rastad, E. Szabó, G. Westin, and G. Åkerström Reduced Parathyroid Vitamin D Receptor Messenger Ribonucleic Acid Levels in Primary and Secondary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2000 - 2003. [Abstract] [Full Text]

				N. Chikatsu, S. Fukumoto, Y. Takeuchi, M. Suzawa, T. Obara, T. Matsumoto, and T. Fujita Cloning and Characterization of Two Promoters for the Human Calcium-sensing Receptor (CaSR) and Changes of CaSR Expression in Parathyroid Adenomas J. Biol. Chem., March 10, 2000; 275(11): 7553 - 7557. [Abstract] [Full Text] [PDF]

				F. Farnebo, B. T. Teh, S. Kytölä, A. Svensson, C. Phelan, K. Sandelin, N. W. Thompson, A. Höög, G. Weber, L.-O. Farnebo, et al. Alterations of the MEN1 Gene in Sporadic Parathyroid Tumors J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2627 - 2630. [Abstract] [Full Text]

				T. Carling, J. Rastad, G. Åkerström, and G. Westin Vitamin D Receptor (VDR) and Parathyroid Hormone Messenger Ribonucleic Acid Levels Correspond to Polymorphic VDR Alleles in Human Parathyroid Tumors J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2255 - 2259. [Abstract] [Full Text]